Chemomab Therapeutics Ltd.
Pharmaceutical company · Tel Aviv, Israel · Nasdaq: CMMB
Chemomab Therapeutics Ltd. is a pharmaceutical company headquartered in Tel Aviv, Israel. Its shares trade on Nasdaq under the ticker CMMB. It has reported private securities offerings to the US SEC, most recently $10 million sold in a notice filed in 2024.
Chemomab Therapeutics at a glance
What does Chemomab Therapeutics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $10 million sold (2024).
Frequently asked questions about Chemomab Therapeutics
Where is Chemomab Therapeutics headquartered?
Chemomab Therapeutics Ltd. is headquartered in Tel Aviv, Israel.
What does Chemomab Therapeutics do?
Chemomab Therapeutics Ltd. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Chemomab Therapeutics a public company?
Yes. Chemomab Therapeutics Ltd. trades on Nasdaq under the ticker CMMB.
Similar companies
- RedHill Biopharma Ltd.Tel Aviv, Israel
- Nasus Pharma LtdTel Aviv, Israel
- PRF Technologies Ltd.Tel Aviv, Israel
- Enlivex Ltd.Tel Aviv, Israel
- Teva Pharmaceutical Industries LtdTel Aviv, Israel
- SciSparc Ltd.Tel Aviv, Israel
- UroGen Pharma Ltd.Ra'anana, Central District, Israel
- MediWound Ltd.Yavné, Central District, Israel
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences